Kementec Solutions A/S: Financial statements 2012
CVR: 25806735
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 10,385,561 and a net result of DKK 1,106,625. Equity in the 2012 report amounted to DKK 3,631,988. The solvency ratio was 48.2%.
- Gross Profit
- DKK 10,385,561
- Profit/Loss
- DKK 1,106,625
- Equity
- DKK 3,631,988
- Total Assets
- DKK 7,533,282
Official annual report
Keep an eye on Kementec Solutions A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.